OPTIGO BIOTHERAPEUTICS

Optigo Biotherapeutics is an innovative pre-clinical stage biotherapeutics company working to develop cutting-edge treatments to address vision loss from chronic ophthalmic diseases, many of which are currently treated by monthly or bimonthly injections of drugs into the eye(s) by a retina specialist. We believe that by reducing the frequency at which each dose of drug is delivered, we will reduce the inconvenience, discomfort, risk and expense of existing treatments. In doing so, we hope to r... educe the number of patients dropping out of their treatment cycles or having to skip doses due to inconvenient timing. Optigo Bio’s therapies for Age-related Macular Degeneration and Diabetic Retinopathy aim to prevent vision loss from these blinding retinal diseases with far fewer injections into the eye.More